Study Highlights Reduced Disease Severity When Vaccinated Against RSV
The severity of RSV disease among adults further highlights how crucial vaccine polices and recommendations are.
Source: pharmacytimes.com
Priority Review Application News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Priority Review Application. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Priority Review Application Today - Breaking & Trending Today
Long Time Coming: Pediatric Gastroenterologists React to New Dupilumab EoE Approval
Following the January 25, 2024 approval of dupilumab for eosinophilic esophagitis in patients 1-11 years of age, a trio of pediatric gastroenterologists shares their thoughts on the new indication, their anticipated priority of use, and potential hurdles to optimal treatment uptake.
Source: hcplive.com
Dupilumab's Role in Managing Pediatric EoE, with Evan Dellon, MD, MPH
We sat down with Evan Dellon, MD, MPH, to discuss the use of dupilumab in pediatric EoE patients, with the agent gaining FDA approval as the first and only indication for this patient population on January 25, 2024.
Source: hcplive.com
Lobe Sciences Ltd outlines "ambitious but doable" plans for 2023
Lobe Sciences Ltd (CSE:LOBE, OTCQB:LOBED) said it expects to have two active Investigational New Drug applications in progress with the US Food and Drug...
Source: proactiveinvestors.com